Condition: Generalized Anxiety · Fear of Failure · Rumination · Sponsor: University of Social Sciences and Humanities, Warsaw
The aim of the study is to examine the effect of imagery rescripting (ImRs) in the context of utilizing large language models (LLMs). Intervention will involve the prior presentation of the most aversive fragment of the memory, the so-called 'hotspot.' This intervention will allow for the replication of the effect described by Dibbets and Arntz (2016), according to which the prior activation of the most emotional element of a memory enhances the effectiveness of ImRs. The study is also significant due to another ongoing study in which a substantial number of participants have already been examined; however, due to the exhaustion of funds, it was not possible to utilize the remainder of the recruited sample. Investigating an additional condition will allow for a more complete utilization of the available participant pool and significantly increase the project's scientific value by comparing the traditional ImRs mechanism with its AI-generated version.
This description comes directly from the study's public registry record.
Stanisław Karkosz, MA · +48 570 668 996 · skarkosz@swps.edu.pl
Always discuss trial participation with your own doctor first.
| SWPS University (University of Social Sciences and Humanities); Poznań Laboratory of Affective Neuroscience | Poznan, Wielkopolska, Poland | Recruiting |
| SWPS University of Social Sciences and Humanities; Poznań Laboratory of Affective Neuroscience | Poznan, Wielkopolska, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07565714